YES
I can’t predict but many areas of the market look awesome from a price perspective. It is a feeding frenzy.
I am off margin and feeling completely underinvested. No one away from Wall Street owns stocks. The average investor is long housing stocks, Yahoo (I am long but for the right reasons :) ), Ebay and oil I think. They wish they owned gold as a hedge against the end of the world. Yutz’s.
It is very calm and rotational unless you own oil. I own some USO and it truly is my only losing position right now. It was a stupid broken buy/trade in the low $50’s and a stupid hold here. I am holding :) and stupid .
Those assanine Goldman Sachs calls for $100 oil when oil was at $80 should be jammed down their throats. I have not heard that call now in a while. Oil would have to double from today’s prices.
Price targets are absurd and reduce credibility.
I am very interested in the price action of the BBH (Biotechs ETF). Amgen and Genentech are the household names. They have marked time for 2-3 years in wide chop and they could be ripe (no positions).
DNA is a safe buy.
BWLD is for men.
thats market wisdom my man. CNBC should be banging on your door. Lucky for you they wont.
Broker A
I am long carbs so buffalo wings is likely a homerun :)
check out my bod in tomorrows show – hint
broker a – everything is a safe buy if you know how to get out ahead of time.
Sorry – I mean broker A, the trader known previously as FLY
I’m digging WU here. I think it deserves another “Fly Buy.”
whos stopping you kid. Interesting company and play on Mexico for sureby
please write a filty show for us on the subject.
Mexicans love WU and I love Mexicans for using WU.
I can’t write a show. Too busy thinking about how much money I am going to make on my next pick– which has yet to be decided.
I hear MNOV is gonna get some fresh investors.
Just throwin a log on the fire.
not hard to hate a loser when it’s oil dropping.
I grabbed XBI (another biotech tracking ETF) earlier in ’07 based on what I saw in sector rotation. It’s been good to me so far. I don’t think my position sizing adequately controls risk for individual biotech companies and don’t want to show my ignorance by picking one over another, so I bought the sector.